{"id":3635,"date":"2024-01-24T14:44:22","date_gmt":"2024-01-24T14:44:22","guid":{"rendered":"http:\/\/drhimanshuyadav.com\/cureus-pembrolizumab-induced-colitis-and-diarrhea-in-the-treatment-of-sporadic-colorectal-cancer-a-case-report-pembrolizumab-is-an-immune-checkpoint-that-blocks-programmed-cell-death-receptor-1-pd-1\/"},"modified":"2024-01-24T14:44:22","modified_gmt":"2024-01-24T14:44:22","slug":"cureus-pembrolizumab-induced-colitis-and-diarrhea-in-the-treatment-of-sporadic-colorectal-cancer-a-case-report-pembrolizumab-is-an-immune-checkpoint-that-blocks-programmed-cell-death-receptor-1-pd-1","status":"publish","type":"post","link":"https:\/\/drhimanshuyadav.com\/blog\/cureus-pembrolizumab-induced-colitis-and-diarrhea-in-the-treatment-of-sporadic-colorectal-cancer-a-case-report-pembrolizumab-is-an-immune-checkpoint-that-blocks-programmed-cell-death-receptor-1-pd-1\/","title":{"rendered":"Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)&#8230;15 hours ago"},"content":{"rendered":"<p>Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)&#8230;15 hours ago<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)&#8230;15 hours ago<\/p>\n","protected":false},"author":2,"featured_media":3636,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[2451,3,1576,348,2452,410,24,1476,2373,534,435,2453,1277,708,2454,2455,2456,2457,2458,2459,676,2460,15],"class_list":["post-3635","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-colorectal-cancer","tag-blocks","tag-cancer","tag-case","tag-cell","tag-checkpoint","tag-colitis","tag-colorectal","tag-cureus","tag-death","tag-diarrhea","tag-hours","tag-ici-15","tag-immune","tag-inhibitor","tag-mainstay","tag-pd1","tag-pembrolizumab","tag-pembrolizumabinduced","tag-programmed","tag-receptor1","tag-report","tag-sporadic","tag-treatment"],"_links":{"self":[{"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/posts\/3635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/comments?post=3635"}],"version-history":[{"count":0,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/posts\/3635\/revisions"}],"wp:attachment":[{"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/media?parent=3635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/categories?post=3635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/tags?post=3635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}